Results 161 to 170 of about 59,250 (306)

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer. [PDF]

Eur Thyroid J
Bondet de La Bernardie S, Bernier MO, Buffet C, Lussey-Lepoutre C, Baudin C.   +4 more
europepmc   +1 more source

Use of Free Flaps in the Reconstruction of the Ventral Skull Base: A Systematic Literature Review

Head &Neck, EarlyView.
ABSTRACT Background Reconstruction of the ventral skull base represents a challenge in head and neck surgery. When local or regional flaps are insufficient, microvascular free flaps offer a reliable reconstructive option. Methods A systematic literature review was conducted following PRISMA guidelines to identify studies on ventral skull base ...
Francesco Mazzola, Francesco Benvegnù, Milena Fior, Martina Conti, Stefano Taboni, Enzo Emanuelli, Philippe Herman, Piero Nicolai, Elisabetta Zanoletti, Raul Pellini, Marco Ferrari   +10 more
wiley   +1 more source

Radiotherapy for the management of bone metastases in differentiated thyroid cancer. [PDF]

Clin Transl Radiat Oncol
Faulkner C, Mesci A, Alfadli F, Brierley JD, Tsang R, Ye XY, Mete O, Ma L, Barron C, Krzyzanowska MK, Lukovic J.   +10 more
europepmc   +1 more source

Thyroid nodule and differentiated thyroid cancer

, 2014
It is difficult to establish a precise definition of a thyroid nodule (TN) since it does not constitute a specific nosological or anatomopathological entity, to the extent that practically any thyroid disease can present in the form of one or more TNs.
Cimarra, Luis, Berriel, Edgardo
openaire   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

Head &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa   +11 more
wiley   +1 more source

Thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer: interpretation, challenges, and future perspectives. [PDF]

J Mol Endocrinol
Links MH, Links TP, Zandee WT, Muller Kobold AC.   +3 more
europepmc   +1 more source

Case Report: Large Cell Neuroendocrine Carcinoma of the Palatine Tonsil in a 76‐Year‐Old Patient

Head &Neck, EarlyView.
ABSTRACT Background Large cell neuroendocrine carcinoma (LCNEC) of the palatine tonsil is an extremely rare malignancy characterized by an aggressive clinical course and poor prognosis. Its nonspecific presentation often delays diagnosis. Methods We present the case of a 76‐year‐old female patient admitted to the Emergency Department with throat ...
Agnieszka Bugaj, Natalia Zagozda, Piotr Nogal, Gabriela Miczuga, Bartosz Czech, Jacek Banaszewski   +5 more
wiley   +1 more source

Recurrence risk of differentiated thyroid cancer treated with total or hemithyroidectomy: systematic review and meta-analysis. [PDF]

Eur Thyroid J
Piccardo A, Fiz F, Bottoni G, Treglia G, Trimboli P.   +4 more
europepmc   +1 more source

New medical treatments in thyroid cancer

, 2014
: Thyroid cancers are rare diseases and include types that range from indolent localised differentiated carcinomas to fulminant and lethal anaplastic disease.
Corn\ue9lis, F., Joosens, E., Clement, P., Decoster, L., Henry, S., Specenier, Pol   +5 more
core  

Challenges in the management of bone metastases: focus on differentiated thyroid cancer and neuroendocrine tumors. [PDF]

J Endocr Soc
Chen J, Wu JY.
europepmc   +1 more source